Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00641
|
|||||
| Drug Name |
Genistein
|
|||||
| Synonyms |
4 inverted exclamation marka,5,7-Trihydroxyisoflavone; 4′,5,7-Trihydroxyisoflavone; 4',5, 7-Trihydroxyisoflavone; 4',5,7-Trihydroxy isoflavone; 4',5,7-Trihydroxyisoflavone; 4,5,7-Trihydroxyiso-flavone; 4,6,7-Trihydroxyisoflavone; 5,7,4'-Trihydroxyisoflavone; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-4-benzopyrone; 5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one; 5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one; Bonistein; C.I. 75610; Differenol A; ENDOCRINE DISRUPTOR (GENISTEIN) (SEE ALSO GENISTEIN (446-72-0)); G 6649; G10000; GEN; GENISTEIN (ENDOCRINE DISRUPTER); Genestein; Genisteol; Genisterin; IN1327; Lactoferrin-genistein; NPI 031L; PTI G4660 (Genistein); PTI-G4660; Prunetol; SIPI 807-1; SIPI-9764-I; STO514; Sophoricol; TNP00151
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Prostate cancer [ICD11: 2C82] | Phase 2 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H10O5
|
|||||
| Canonical SMILES |
C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O
|
|||||
| InChI |
InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)11-7-20-13-6-10(17)5-12(18)14(13)15(11)19/h1-7,16-18H
|
|||||
| InChIKey |
TZBJGXHYKVUXJN-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 446-72-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 270.24 | Topological Polar Surface Area | 87 | ||
| Heavy Atom Count | 20 | Rotatable Bond Count | 1 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
2.7
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10318994
, 11111233
, 11111234
, 11113921
, 11114608
, 11120325
, 11120813
, 11121301
, 11341576
, 11361759
, 11363214
, 11364972
, 11365776
, 11367534
, 11368338
, 11370096
, 11371695
, 11373135
, 11375144
, 11375696
, 11376500
, 11378267
, 11404364
, 11407761
, 11484372
, 11487161
, 11488454
, 11490494
, 11493357
, 11494134
, 15197341
, 17389520
, 17405083
, 22391506
, 24278036
, 24895273
, 25622056
, 26527427
, 3153130
, 4652582
, 606653
, 640215
, 7887819
, 8138208
, 8144401
, 854585
, 854586
, 8616462
, 8792
, 93197
|
|||||
| ChEBI ID |
ChEBI:28088
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT02624388) Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) (UVA-Gen001) | |||||
| 2 | Differential selectivity of efflux transporter inhibitors in Caco-2 and MDCK-MDR1 monolayers: a strategy to assess the interaction of a new chemical entity with P-gp, BCRP, and MRP2. J Pharm Sci. 2012 May;101(5):1888-97. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.